
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1079 | 1062 | 1079 | 998 | 1391 | - |
Fund Return | 7.89% | 6.23% | 7.89% | -0.05% | 6.82% | - |
Place in category | 54 | 41 | 54 | 48 | 17 | - |
% in Category | 50 | 28 | 50 | 62 | 36 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Affin Hwang Select Income Fund | 1.07B | 0.67 | 1.47 | 3.27 | ||
Affin Hwang Select Opportunity Fund | 918.66M | -5.19 | 8.32 | 5.75 | ||
MYU930000CF8 | 691.7M | 2.19 | -5.53 | 4.92 | ||
Affin Hwang Select Asia ex Japan Op | 656.15M | -0.31 | -4.56 | 3.84 | ||
MYU930000FK1 | 119.85M | 8.79 | -16.70 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Public Islamic Asia Tactical Alloca | 2.39B | -1.34 | 0.20 | 6.41 | ||
Public Tactical Allocation Fund | 630.53M | 2.85 | 0.25 | 5.44 | ||
PB Dynamic Allocation Fund | 556.26M | 2.06 | 5.19 | 6.84 | ||
Affin Hwang Absolute Return Fund II | 307.98M | 2.82 | 2.43 | 5.21 | ||
Manulife Investment ML Flexi Fund | 98.13M | -4.72 | 7.85 | 5.05 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nikko AM Global Equity B USD Acc | LU1198276120 | 9.88 | - | - | |
iShares Core S&P 500 UCITS | IE00B5BMR087 | 9.56 | 630.45 | +0.87% | |
Affin Hwang Select Opportunity Fund | MYU930000CM4 | 8.08 | 1.200 | -1.85% | |
JPMorgan ETFs (Ireland) ICAV - Global Research Enh | IE00BF4G6Y48 | 8.07 | 51.81 | +1.05% | |
GQG Partners US Equity I USD Acc | IE00BN4GYG85 | 8.01 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Sell | BUY |
Summary | Strong Sell | Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review